Ziyi Luo

477 total citations
18 papers, 370 citations indexed

About

Ziyi Luo is a scholar working on Molecular Biology, Biomedical Engineering and Epidemiology. According to data from OpenAlex, Ziyi Luo has authored 18 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Epidemiology. Recurrent topics in Ziyi Luo's work include Tuberculosis Research and Epidemiology (2 papers), Mycobacterium research and diagnosis (2 papers) and Carbon and Quantum Dots Applications (2 papers). Ziyi Luo is often cited by papers focused on Tuberculosis Research and Epidemiology (2 papers), Mycobacterium research and diagnosis (2 papers) and Carbon and Quantum Dots Applications (2 papers). Ziyi Luo collaborates with scholars based in China. Ziyi Luo's co-authors include Shunyao Zhu, Fuling Zhou, Xixi Li, Ting Zhang, Xi Han, Yujia Zheng, Balu Wu, Yongchang Wei, Dongdong Zhang and Xuejia Hu and has published in prestigious journals such as Blood, Cancer Research and Free Radical Biology and Medicine.

In The Last Decade

Ziyi Luo

15 papers receiving 365 citations

Peers

Ziyi Luo

IMMUN

ONCOL

Tianji Wang China

Emily Thompson United Kingdom

Jieying Qian China

Jiashe Chen China

Xiaoran Yang China

Mengdi Song China

Maha Ali Alghamdi Saudi Arabia

Claudia Giliberti Italy

Angelico Bedini Italy

Tianji Wang China

Ziyi Luo

134 ×0.7

102 ×1.0

95 ×1.5

81 ×1.4

IMMUN

61 ×1.4

ONCOL

Citations per year, relative to Ziyi Luo Ziyi Luo (= 1×) peers Tianji Wang

Countries citing papers authored by Ziyi Luo

Since Specialization

Citations

This map shows the geographic impact of Ziyi Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ziyi Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ziyi Luo more than expected).

Fields of papers citing papers by Ziyi Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ziyi Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ziyi Luo. The network helps show where Ziyi Luo may publish in the future.

Co-authorship network of co-authors of Ziyi Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Ziyi Luo. A scholar is included among the top collaborators of Ziyi Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ziyi Luo. Ziyi Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Li, Peng, Jie Lin, Jun Liu, et al.. (2025). Integrative analysis of immunogenic PANoptosis and experimental validation of cinobufagin-induced activation to enhance glioma immunotherapy. Journal of Experimental & Clinical Cancer Research. 44(1). 35–35. 10 indexed citations

Zhu, Weijie, et al.. (2024). Machine learning-based identification of histone deacetylase-associated prognostic factors and prognostic modeling for low-grade glioma. Discover Oncology. 15(1). 824–824.

Luo, Ziyi, et al.. (2024). A comprehensive analysis of the pyruvate kinase M1/2 (PKM) in human cancer. Gene. 937. 149155–149155. 3 indexed citations

Zhu, Shunyao, et al.. (2023). Combined immunochemotherapy achieving targeted co-delivery of chlorogenic acid and doxorubicin by sialic acid-modified liposomes enhances anti-cancer efficacy. Drug Delivery and Translational Research. 14(3). 718–729. 15 indexed citations

Luo, Quan, Ziyi Luo, Hui Zeng, et al.. (2022). A new HClO-activated “turn-off” mitochondria-targetable NIR fluorescent probe for imaging of osteoarthritis in vivo. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 273. 121017–121017. 19 indexed citations

Chen, Yanling, Ziyi Luo, & Fuling Zhou. (2021). Study on Anti-Acute Mononuclear Leukemia Activity and Mechanism of Lentinus Edodes Derived β-Glucan/ Selenium Nanoparticles Composites. Blood. 138(Supplement 1). 3335–3335. 3 indexed citations

Zhao, Shukun, Xuejia Hu, Jiaomeng Zhu, et al.. (2021). On-chip rapid drug screening of leukemia cells by acoustic streaming. Lab on a Chip. 21(20). 4005–4015. 31 indexed citations

Zhu, Shunyao, et al.. (2020). Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications. Journal of Cancer. 12(1). 54–64. 57 indexed citations

Jin, Yanxia, Liqin Cai, Qian Yang, et al.. (2020). Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helix β-d-glucan. Carbohydrate Polymers. 240. 116329–116329. 47 indexed citations

10.

Zhang, Dongdong, Ziyi Luo, Yanxia Jin, et al.. (2020). Azelaic Acid Exerts Antileukemia Effects against Acute Myeloid Leukemia by Regulating the Prdxs/ROS Signaling Pathway. Oxidative Medicine and Cellular Longevity. 2020. 1–16. 17 indexed citations

11.

Hu, Xuejia, Shukun Zhao, Ziyi Luo, et al.. (2020). On-chip hydrogel arrays individually encapsulating acoustic formed multicellular aggregates for high throughput drug testing. Lab on a Chip. 20(12). 2228–2236. 54 indexed citations

12.

Jin, Yanxia, Liqin Cai, Qian Yang, et al.. (2020). Abstract 586: Anti-leukemia activities of selenium nanoparticles embedded in nanotube consisted of triple-helix β-D-glucan. Cancer Research. 80(16_Supplement). 586–586. 1 indexed citations

13.

Zheng, Yujia, Qianqian Li, Jing Wu, et al.. (2020). All-in-one mitochondria-targeted NIR-II fluorophores for cancer therapy and imaging. Chemical Science. 12(5). 1843–1850. 71 indexed citations

14.

Zhang, Dongdong, Yujiao Liu, Ziyi Luo, et al.. (2019). The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia. Free Radical Biology and Medicine. 146. 275–286. 19 indexed citations

15.

Cui, Zhenling, Ziyi Luo, Zilu Wen, et al.. (2016). Multi-Fluorescence Real-Time PCR Assay for Detection of RIF and INH Resistance of M. tuberculosis. Frontiers in Microbiology. 7. 618–618. 16 indexed citations

16.

Wu, Yumei, et al.. (2010). [The association between NAT2 polymorphism and anti-tuberculosis drug-induced hepatitis].. PubMed. 18(6). 467–9. 6 indexed citations

17.

Yuan, Jing, Weiye Yu, Yiwen Hu, et al.. (2004). [Clinical features of 23 cases of AIDS complicated by tuberculosis].. PubMed. 27(11). 767–70. 1 indexed citations

18.

Lu, Pu-Xuan, Boping Zhou, Yiwen Hu, et al.. (2003). [Clinical and chest X-ray characteristics of 5 cases with severe acute respiratory syndrome in children in Shenzhen area].. PubMed. 41(9). 645–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact